Ad is loading...
DNLI
Price
$24.22
Change
-$0.20 (-0.82%)
Updated
Nov 21 closing price
101 days until earnings call
PEPG
Price
$4.32
Change
-$0.08 (-1.82%)
Updated
Nov 21 closing price
118 days until earnings call
Ad is loading...

DNLI vs PEPG

Header iconDNLI vs PEPG Comparison
Open Charts DNLI vs PEPGBanner chart's image
Denali Therapeutics
Price$24.22
Change-$0.20 (-0.82%)
Volume$1.48M
CapitalizationN/A
PepGen
Price$4.32
Change-$0.08 (-1.82%)
Volume$82.11K
CapitalizationN/A
DNLI vs PEPG Comparison Chart
Loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PEPG
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
DNLI vs. PEPG commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNLI is a StrongSell and PEPG is a Sell.

COMPARISON
Comparison
Nov 22, 2024
Stock price -- (DNLI: $24.22 vs. PEPG: $4.32)
Brand notoriety: DNLI and PEPG are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNLI: 177% vs. PEPG: 80%
Market capitalization -- DNLI: $3.51B vs. PEPG: $143.42M
DNLI [@Biotechnology] is valued at $3.51B. PEPG’s [@Biotechnology] market capitalization is $143.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $463.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNLI’s FA Score shows that 0 FA rating(s) are green whilePEPG’s FA Score has 1 green FA rating(s).

  • DNLI’s FA Score: 0 green, 5 red.
  • PEPG’s FA Score: 1 green, 4 red.
According to our system of comparison, both DNLI and PEPG are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNLI’s TA Score shows that 3 TA indicator(s) are bullish while PEPG’s TA Score has 3 bullish TA indicator(s).

  • DNLI’s TA Score: 3 bullish, 7 bearish.
  • PEPG’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, PEPG is a better buy in the short-term than DNLI.

Price Growth

DNLI (@Biotechnology) experienced а -14.87% price change this week, while PEPG (@Biotechnology) price change was -3.79% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.74%. For the same industry, the average monthly price growth was -7.78%, and the average quarterly price growth was +1.53%.

Reported Earning Dates

DNLI is expected to report earnings on Mar 03, 2025.

PEPG is expected to report earnings on Mar 20, 2025.

Industries' Descriptions

@Biotechnology (-3.74% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNLI($3.52B) has a higher market cap than PEPG($143M). DNLI YTD gains are higher at: 12.861 vs. PEPG (-36.471). PEPG has higher annual earnings (EBITDA): -90.04M vs. DNLI (-496.05M). DNLI has more cash in the bank: 837M vs. PEPG (139M). PEPG has less debt than DNLI: PEPG (19M) vs DNLI (52.5M). DNLI (0) and PEPG (0) have equivalent revenues.
DNLIPEPGDNLI / PEPG
Capitalization3.52B143M2,458%
EBITDA-496.05M-90.04M551%
Gain YTD12.861-36.471-35%
P/E RatioN/AN/A-
Revenue00-
Total Cash837M139M602%
Total Debt52.5M19M276%
FUNDAMENTALS RATINGS
DNLI: Fundamental Ratings
DNLI
OUTLOOK RATING
1..100
63
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
PROFIT vs RISK RATING
1..100
85
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DNLIPEPG
RSI
ODDS (%)
Bearish Trend 1 day ago
79%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
76%
N/A
Momentum
ODDS (%)
Bearish Trend 1 day ago
78%
N/A
MACD
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 4 days ago
87%
Declines
ODDS (%)
Bearish Trend 5 days ago
78%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
72%
Bearish Trend 1 day ago
89%
View a ticker or compare two or three
Ad is loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PEPG
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CCASX81.921.66
+2.07%
Conestoga Small Cap Investors
QSMLX20.370.30
+1.49%
AQR Small Cap Multi-Style I
AWACX22.710.11
+0.49%
AB Wealth Appreciation Strategy C
DGQUX7.87N/A
N/A
DSS AmericaFirst Total Return Bond U
NSCKX31.29N/A
N/A
Northern Small Cap Core K

DNLI and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNLI has been loosely correlated with BEAM. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if DNLI jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNLI
1D Price
Change %
DNLI100%
-0.82%
BEAM - DNLI
63%
Loosely correlated
-3.72%
ALEC - DNLI
57%
Loosely correlated
+3.44%
JANX - DNLI
55%
Loosely correlated
-5.02%
RCKT - DNLI
54%
Loosely correlated
-1.92%
LGND - DNLI
54%
Loosely correlated
+4.47%
More

PEPG and

Correlation & Price change

A.I.dvisor indicates that over the last year, PEPG has been loosely correlated with PRTA. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if PEPG jumps, then PRTA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PEPG
1D Price
Change %
PEPG100%
-1.82%
PRTA - PEPG
53%
Loosely correlated
+0.28%
ABOS - PEPG
37%
Loosely correlated
-2.53%
FGEN - PEPG
31%
Poorly correlated
+10.63%
DNLI - PEPG
29%
Poorly correlated
-0.82%
GRI - PEPG
28%
Poorly correlated
+7.82%
More